Paper Review Records
全部论文审稿周期
15 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
70
天
Phase I Evaluation of Siltartoxatug, a First‐in‐Class Anti‐Tetanus Monoclonal Antibody: Safety, Pharmacokinetics and Pharmacodynamics in Healthy Australian and Chinese Populations
作者
Xinyu Liu; Zhigang Liu; Xiaohu Kuang; Yueming Wang; Xiaoyi Liu; Jiyuan Ding; Xia Zhou; Xin Zhou; Qianyu Liang; Meizhuo Zhang; Hao Zhao; Qingqing Tan; Weihong Zheng; Huaxin Liao; Charlotte Lemech; Wanmei Wang展开收起
作者单位
1. Zhuhai Trinomab Pharmaceutical Co., Ltd. Zhuhai China; 2. The Fifth Affiliated Hospital Sun Yat‐sen University Zhuhai China; 3. Present address: Cancer Center, The Tenth Affiliated Hospital Southern Medical University (Dongguan People's Hospital) Dongguan China; 4. Scientia Clinical Research Ltd. Sydney Australia展开收起
195
天
Exposure–Response Analysis of Enfortumab Vedotin Plus Pembrolizumab as First‐Line Therapy for Locally Advanced or Metastatic Urothelial Cancer
作者
Vaishali L. Chudasama; Helen Kastrissios; Hossam Kadry; Daping Zhang; Salaheldin Hamed; Srinivasu Poondru; Souvik Bhattacharya; Russ Wada; Amit Garg; Yen Lin Chia展开收起
作者单位
1. Pfizer Inc New York New York USA; 2. QuanTx Consulting Mountain View California USA; 3. Astellas Pharma Northbrook Illinois USA; 4. BeOne Medicines San Carlos California USA展开收起
103
天
Effects of Fomepizole on Acetaminophen Oxidative Metabolism: A Randomized, Crossover Study in Human Volunteers
作者
Sidharth Anand; Nicholas A. Buckley; Paul Stathakis; Laura James; Larry Parker; Mitchell R. McGill; Angela L Chiew展开收起
作者单位
1. Faculty of Medicine The University of New South Wales Sydney New South Wales Australia; 2. Faculty of Medicine and Health The University of Sydney Camperdown New South Wales Australia; 3. NSW Health Pathology, Prince of Wales Hospital Randwick New South Wales Australia; 4. Department of Pediatrics, College of Medicine University of Arkansas for Medical Sciences Little Rock Arkansas USA; 5. Acetaminophen Toxicity Diagnostics, LLC Little Rock Arkansas USA; 6. Department of Environmental Health Sciences, Fay W. Boozman College of Public Health University of Arkansas for Medical Sciences Little Rock Arkansas USA; 7. Department of Pharmacology and Toxicology, College of Medicine University of Arkansas for Medical Sciences Little Rock Arkansas USA; 8. Department of Clinical Toxicology Prince of Wales Hospital Randwick New South Wales Australia展开收起
117
天
Epcoritamab Step‐Up Dosing Regimen Selection and Optimization Using Repeated Time‐to‐Event Modeling for Cytokine Release Syndrome Risk Mitigation
作者
Tommy Li; Andrew Tredennick; Daniel Polhamus; Matthew Putnins; Sihang Liu; Kinjal Sanghavi; Craig J. Thalhauser; Apurvasena Parikh; Behnam Noorani; Mohamed‐Eslam F. Mohamed; Chris Le Gallo; Brian Elliott; Manish Gupta; Steven Xu展开收起
作者单位
1. Genmab Princeton New Jersey USA; 2. Metrum Research Group Boston Massachusetts USA; 3. AbbVie Inc. North Chicago Illinois USA展开收起
125
天
From Executor to Orchestrator: The Pharmacology Scientist in the Age of Agentic AI
作者
Michael McCoy; Matthew McCoy展开收起
作者单位
1. Drug Metabolism and Pharmacokinetics & Modeling, Takeda Development Center Americas Cambridge Massachusetts USA; 2. Independent Researcher Kansas City Missouri USA展开收起
9
天
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿62 天
中位数65 天